ARCHIVES

Clinical Trials: Phase I Trial of Karenitecin Begins, BioNumerik Says

This article is from The Cancer Letter archive.

Vol. 25 No. 09 | March 5, 1999

Download PDF Visit The Full Archive

Related Articles

Braun Named Executive Director Of ASCO Foundation

November 17, 2006

Self-Collected Pap Smear Tests Could Advance HPV Screening

January 27, 2012

Appropriations Committees Lean Toward Adding Some To NCI Budget; ACS To Ask Again For $1.5 Billion

April 20, 1984

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

April 25, 2014

NCI-Approved Clinical Trials

April 29, 2005

Onco TCS Induces Responses In Relapsed Aggressive NHL

February 28, 2003